US Patent 11254726 LILRB1-based chimeric antigen receptor
Patent 11254726 was granted and assigned to A2 Biotherapeutics, Inc on February, 2022 by the United States Patent and Trademark Office.
Is a
Current Assignee
Date Filed
April 14, 2021
0
Date of Patent
February 22, 2022
0
Patent Applicant
Patent Application Number
17230637
0
Patent Inventor Names
Kiran Deshmukh
0
Mark E. Daris
0
Carl Alexander Kamb
0
Agnes E. Hamburger
0
Breanna Diandreth
0
Patent Jurisdiction
Patent Number
Patent Primary Examiner
Find more entities like US Patent 11254726 LILRB1-based chimeric antigen receptor
Use the Golden Query Tool to find similar entities by any field in the Knowledge Graph, including industry, location, and more.
